Literature DB >> 7545676

Tyrosine phosphorylation of p130Cas and cortactin accompanies integrin-mediated cell adhesion to extracellular matrix.

K Vuori1, E Ruoslahti.   

Abstract

We show in this report that two v-src substrate proteins, p130Cas and cortactin, become tyrosine-phosphorylated during integrin-mediated cell adhesion to extracellular matrix substrata and upon cell attachment onto immobilized anti-integrin antibodies. This tyrosine phosphorylation does not occur when cells attach to polylysine or through antibodies against major histocompatibility complex. It also does not take place when adhesion-mediated reorganization of the actin cytoskeleton is inhibited with cytochalasin D. Tyrosine phosphorylation of p130Cas and cortactin coincides with tyrosine phosphorylation of focal adhesion kinase during integrin-mediated cell adhesion but is independent of cell adhesion in v-src-transformed cells. The tyrosine-phosphorylated sites in p130Cas and cortactin may serve as binding sites for proteins containing Src homology 2 domains, as is the case with two other integrin-regulated docking proteins, focal adhesion kinase and paxillin. Thus, these results suggest that ligand binding of integrins regulates the tyrosine phosphorylation state of multiple docking proteins. These proteins may mediate anchorage dependence of growth; their misregulation in v-src-transformed and other tumorigenic cells may be responsible for the anchorage independence of such cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7545676     DOI: 10.1074/jbc.270.38.22259

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  78 in total

1.  rab5 GTPase regulates adenovirus endocytosis.

Authors:  T Rauma; J Tuukkanen; J M Bergelson; G Denning; T Hautala
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

2.  CMS: an adapter molecule involved in cytoskeletal rearrangements.

Authors:  K H Kirsch; M M Georgescu; S Ishimaru; H Hanafusa
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-25       Impact factor: 11.205

3.  Crystallization of the SH2-binding site of p130Cas in complex with Lck, a Src-family kinase.

Authors:  Fariborz Nasertorabi; Andres Alonso; Scott W Rogers; Tomas Mustelin; Kristiina Vuori; Lars Liljas; Kathryn R Ely
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2005-01-08

4.  Synthetic D-amino acid peptide inhibits tumor cell motility on laminin-5.

Authors:  Thomas C Sroka; Michael E Pennington; Anne E Cress
Journal:  Carcinogenesis       Date:  2006-03-14       Impact factor: 4.944

Review 5.  Cortactin in cell migration and cancer at a glance.

Authors:  Stacey M MacGrath; Anthony J Koleske
Journal:  J Cell Sci       Date:  2012-04-01       Impact factor: 5.285

Review 6.  The inside story of Shigella invasion of intestinal epithelial cells.

Authors:  Nathalie Carayol; Guy Tran Van Nhieu
Journal:  Cold Spring Harb Perspect Med       Date:  2013-10-01       Impact factor: 6.915

7.  Insulin stimulates the tyrosine dephosphorylation of docking protein p130cas (Crk-associated substrate), promoting the switch of the adaptor protein crk from p130cas to newly phosphorylated insulin receptor substrate-1.

Authors:  A Sorokin; E Reed
Journal:  Biochem J       Date:  1998-09-15       Impact factor: 3.857

8.  SRC points the way to biomarkers and chemotherapeutic targets.

Authors:  Harini Krishnan; W Todd Miller; Gary S Goldberg
Journal:  Genes Cancer       Date:  2012-05

9.  Introduction of p130cas signaling complex formation upon integrin-mediated cell adhesion: a role for Src family kinases.

Authors:  K Vuori; H Hirai; S Aizawa; E Ruoslahti
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

10.  P130Cas-associated protein (p140Cap) as a new tyrosine-phosphorylated protein involved in cell spreading.

Authors:  Paola Di Stefano; Sara Cabodi; Elisabetta Boeri Erba; Valentina Margaria; Elena Bergatto; Maria Gabriella Giuffrida; Lorenzo Silengo; Guido Tarone; Emilia Turco; Paola Defilippi
Journal:  Mol Biol Cell       Date:  2003-12-02       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.